Published in
Springer Nature [academic journals on nature.com], Leukemia, 10(34), p. 2815-2816, 2020
DOI: 10.1038/s41375-020-01038-8
Links
Tools
The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 